A versatile solid-phase total synthesis was applied to the rapid preparation of Argadin, a natural product isolated and characterized as a cyclopentapeptide by our group, which possesses superior inhibitory activity against family-18 chitinases. The synthetic strategy includes peptide synthesis by using an Fmoc (9-fluorenylmethoxycarbonyl) protective group, macrolactamization, acetylguanylation and formation of hemiaminal accompanied by total deprotection, including cleavage from resin.
INTRODUCTION
Chitinases hydrolyze chitin, a linear homopolymer of N-acetyl-Dglucosamine, that is present in a wide range of organisms, including bacteria, fungi, insects, viruses, higher plants and animals, and have a variety of roles in the biological world. [1] [2] [3] Chitinases are currently classified into two different families of glycosyl hydrolases, namely family-18 and family-19, on the basis of amino acid sequence similarities. 4 Family-18 contains chitinases from various organisms, whereas family-19 chitinases are only found in plants and Streptomyces species. As chitin is a major component of fungal cell walls, the exoskeletons of crustaceans and insects, as well as the microfilarial sheaths of parasitic nematodes, family-18 chitinases have important physiological roles in these organisms. [1] [2] [3] Family-18 chitinase inhibitors have thus become a subject of interest owing to their potential as anti-fungal agents, 5 pesticides for controlling pests 6 and promise as insecticides to control disease vectors, such as malaria. 7 They also offer significant potential for the treatment of asthma and other diseases in humans. 8 During the screening for chitinase inhibitors, two new cyclic pentapeptides, Argadin (1) 9 and Argifin (2), [10] [11] [12] were isolated from the cultured broths of Clonostachys sp. FO-7314 and Gliocladium sp. FTD-0668, respectively, by our research group, and found to be potent chitinase inhibitors of blowfly (Lucilia cuprina) 10 and Serratia marcescens chitinases (SmChi), [13] [14] [15] [16] both of which are family-18 chitinases (Figure 1 ). Developments of practical and efficient total syntheses of 1 and 2 are important objectives, as the original sources do not produce these cyclic peptides with sufficient quantities. In fact, the total syntheses of 1 and 2, involving hybrid approaches of solid-and liquidphase reaction sequences, have been reported by Dixon et al. 17, 18 They developed an improved synthetic route for 2 and analogs on the basis of an all-solid-phase approach. 19 More recently, we have independently reported the total synthesis of 2 accomplished by solid-phase synthetic protocols for the entire reaction sequence, except for the final cleavage step from resin. We have also evaluated acyclic peptide analogs of 2 20 and have investigated the application of in situ click chemistry with SmChi to swiftly generate more potent chitinase inhibitors using the simplified structure of natural 2. 21 In this study, we describe our efficient solid-phase total synthesis of 1 using glycerol polystyrene resin along with only one-time HPLC separation at the final step.
RESULTS AND DISCUSSION
Our retrosynthetic analysis for Argadin (1) is outlined in Scheme 1. The cyclic peptide structure of 1 allowed us to adopt a solid-phase synthetic strategy on the basis of an application of an 9-fluorenylmethoxycarbonyl (Fmoc) protective group for the amine of amino acid fragments with allyl protection on the carboxylic acid of the L-aspartic-b-semialdehyde 22 unit. This strategy enables cyclization of the linear precursor that is still attached to a solid support by the side chain of an L-aspartic-b-semialdehyde residue. Our synthetic strategy of 1 offers many advantages, including: (i) the anchorage of the first residue (C terminal) to resin through the side-chain aldehyde function; (ii) the selected glycerol polystyrene resin acts as a protective group of aldehyde for preventing the formation of sensitive cyclic hemiaminal; (iii) on resin, cyclization includes a stepwise selective deprotection of the C and N terminals, followed by intramolecular condensation; (iv) single-step operation to convert to the N o -acetylarginine residue obtained from ornithine by acetylguanylation; and (v) the whole reaction sequence can be carried out on resin, except for the cleavage from resin and hemiaminal formation at the final step.
The synthesis of 1 commenced with the loading of the solid support of the N-Fmoc-O-allyl-protected aspartic acid b-semialdehyde residue (3), 22 anchored by a side chain. The aldehyde in 3 was loaded onto (±)-glycerol polystyrene resin (1.40 mmol g À1 ) in the presence of catalytic TsOH under reflux in 1,4-dioxane to yield 4 with a loading of 41.33 mmol g À1 (Scheme 2). To confirm the loading yield, cleavage Scheme 1 Synthetic plan of 1. Boc, t-butoxycarbonyl; Dde, 1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl; Fmoc, 9-fluorenylmethoxycarbonyl; SPPS, solid-phase peptide synthesis.
Solid-phase total synthesis of Argadin T Hirose et al from the resin 4 with 100% of TFA for 1 h, followed by treatment with morpholinomethyl polystyrene resin (polystyrene-N-methylmorpholine (PS-NMM)) in MeOH/CH 2 Cl 2 (1/1) for 2 h, resulted in the desired glycerol bearing 3 (5) in 98% crude yield with 97% purity (calculated using the liquid chromatography (LC)-UV analysis). The resin-bound amino acid 4 was subsequently subjected to four deprotection-coupling cycles to construct the linear pentapeptide by standard Fmoc solid-phase peptide synthesis using PyBOP ((benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate) activation for peptide formation, except for the condensation between 1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl (Dde)-protected Fmoc-Orn-OH (7) 23,24 and D-Pro, which was accomplished using HBTU (2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluroniumhexafluorophosphate) activation. Each amino acid coupling step was monitored by the LC-UV analysis for the cleaved material using the acid deprotection processes. After the synthesis of the linear pentapeptide (12) was accomplished, deprotection on both the C and N terminals was achieved by subjecting the resin-bound 12 to Pd(PPh 3 ) 4 treatment in the presence of dimedone in DMF under Ar atmosphere to eliminate the allyl function. Subsequently, the Fmoc group was removed by piperidine to afford the precursor of the cyclic peptide compound (14) , which was then converted to the crude product (15) with 97% purity, as determined by the LC-UV analysis (as shown in Scheme 3).
Macrolactamization of 14 under the PyBOP activation condition for 1 h of reaction time proceeded with low efficiency to yield the cyclic peptide 16, which was converted to final Argadin (1) with very low quantity (o1% isolated yield after HPLC separation) by submitting a 3-reaction sequence, deprotection of Dde by 2% NH 2 NH 2 in DMF, acetylguanylation using 1-H-pyrazole-1-[N-(tert-butoxycarbonyl)]-N¢-acetylcarboxamidine (18), 25 followed by the formation of hemiaminal accompanied by total deprotection, including resin cleavage, to roughly elucidate the conversion ratio from 14 to 15 (Scheme 4). Although the two-cycle repetition reaction for lactamiza-tion with 14 (PyBOP, 1 hÂ2) was attempted to improve the conversion yield, the production of 1 was still low (B1% yield). To obtain a sufficient quantity of 1, various condensation reagents, such as HBTU, O-(7-azabenzotriazol-1-yl)-N,N,N¢,N¢-tetramethyluronium hexafluorophosphate (HATU) and PyBrop, were tested. Optimally, when 14 was subjected to the macrolactamization using HATU in the presence of diisopropylethylamine (DIPEA) in CH 2 Cl 2 /DMF (4/1) for 1 h over a two-cycle repetition, Argadin (1) was isolated in 4.7% of the overall yield, after undergoing the three-step reaction sequence and final separation by HPLC (Scheme 4). All spectral data ( 1 H-, 13 9 did not match, partly because of the optical rotational value of 1 being strongly influenced by the counter anion of acids, and the fact that it was difficult to create identical conditions under which to measure the optical rotation. HPLC profiles of both synthetic and natural 1 showed a 3:1 to 7:1 mixture of diastereoisomers at the hemiaminal position. The ratio of diastereomers was also influenced by acidic additives (TFA, AcOH or HCO 2 H), which are usually added into a mobile phase of HPLC, and the stock solution of Argadin samples to stabilize Argadin itself. The diastereomeric ratio of hemiaminal may affect the optical rotational value of Argadin. Therefore, we examined the inhibitory activity of synthetic 1 against chitinases, and its activity was almost the same as that of natural 1.
In conclusion, we completed the solid-phase total synthesis of Argadin (1) using a supported acetal resin. This synthesis was concise and required 15 steps in the longest linear sequence from (±)-glycerol polystyrene resin, with HPLC separation after cleavage from resin to yield 1 in 4.7% of the overall yield. The process allows us to speedily generate a variety of analogs in structure-activity relationship studies. Ongoing studies, aimed at the synthesis and biological evaluation of peptide analogs, designed using computer-aided rational molecular calculations 26 using information obtained from X-ray cocrystallography of Argadin-chitinase, are currently under way in our laboratories.
EXPERIMENTAL SECTION General procedure
Fmoc-D-Pro-OH (5), Fmoc-Ada(Ot-Bu)-OH (9) and Fmoc-(Boc)His-OH (11) were purchased from Watanabe Chemical Industries (Hiroshima, Japan). (±)-Glycerol polystyrene resin (1.4 mmol g À1 ) was purchased from NovaBiochem (Tokyo, Japan). Dry pyridine, THF, DMF, MeOH, 1,4-dioxane and CH 2 Cl 2 were purchased from Kanto Chemical (Tokyo, Japan). 1 H-NMR spectra were recorded at 400 MHz, and 13 C-NMR spectra were recorded at 100 MHz on 4 mmol) was added to the solution of resin, and the reaction mixture was heated to 90 1C using a DeanStark trap. After heating for 8 h, the reaction was cooled to room temperature, filtered to collect the resin product, which was washed with pyridine (10 mlÂ2), Py/H 2 O (1/1) (10 mlÂ2), H 2 O (10 mlÂ2), THF (10 mlÂ2), DMF (10 mlÂ4), dichloromethane (DCM) (10 mlÂ4) and dried in vacuo to afford the desired resin-bound product 4.
General procedure for deprotection of the Fmoc group
The MicroKan microreactor with 30 mg resin was placed into a 20 ml screw vial and swollen in DCM (1.5 ml) for 1 h and thereafter filtered. It was sequentially treated with a solution of 20% piperidine in DMF (1.5 ml). The mixture was vigorously agitated at room temperature. After being agitated for 1 h, the mixture was filtered, washed with DMF (5 mlÂ4), DCM (5 mlÂ4) and dried in vacuo to afford the corresponding resin-bound amine products.
General procedure for peptide coupling
The MicroKan microreactor with 30 mg resin was placed into a 20 ml screw vial and swollen in DMF (1. Procedure for deprotection of the allyl group of 12
The MicroKan microreactor with 12 was placed into a 20 ml screw vial and swollen in THF (1.5 ml) for 1 h under Ar atmosphere, and the remaining THF was thereafter drained by a syringe. To the MicroKan microreactor with 12 was sequentially added a well-mixed solution of Pd(PPh 3 ) 4 (1.5 equiv.) and dimedone (10 equiv.) in THF (1.5 ml) through a syringe under Ar atmosphere. The mixture was vigorously agitated at room temperature under the Ar atmosphere. After being agitated for 1 h, the mixture was filtered, washed with THF (5 mlÂ4), DMF (5 mlÂ4), DCM (5 mlÂ4) and dried in vacuo to afford 13.
Cyclization of 14
The MicroKan microreactor with 14 was placed into a 20 ml screw vial and swollen in DCM (1.5 ml) for 1 h and thereafter filtered. It was treated with a cocktail of HATU (2 equiv.) and DIPEA (4 equiv.) in DCM/DMF (4/1, 1.5 ml). The mixture was vigorously agitated at room temperature. After being agitated for 2 h, the mixture was filtered, washed with DMF (5 mlÂ4), DCM (5 mlÂ4) and dried in vacuo. The same procedure was repeated.
Procedure for deprotection of Dde in 16
The MicroKan microreactor with 16 was placed into a 20 ml screw vial and swollen in DMF (1.5 ml) for 1 h, and filtered. It was sequentially treated with a solution of 2% hydrazine monohydrate in DMF (1.5 ml). The mixture was vigorously agitated at room temperature. After being agitated for 1 h, the reaction mixture was filtered, washed with DMF (5 mlÂ4), DCM (5 mlÂ4) and dried in vacuo to afford 17.
Procedure for acetylguanylation of 17
The MicroKan microreactor with 17 was placed into a 20 ml screw vial and swollen in DCM (1.5 ml) for 1 h and thereafter filtered. The MicroKan microreactor was sequentially treated with a 1.0 M solution of 18 25 in DCM (126 ml) and N,N-diisopropylethylamine (43.9 ml, 252 mmol) in DCM/DMF (4/1, 1.5 ml). The mixture was vigorously agitated at room temperature. After being agitated for 2 h, the reaction mixture was filtered, washed with DMF (5 mlÂ4), DCM (5 mlÂ4) and dried in vacuo to afford 19.
Cleavage from the resin and hemiaminal formation to yield 1
The MicroKan microreactor with 19 was placed into a 20 ml screw vial and swollen in DCM (1.5 ml) for 1 h and thereafter filtered. It was sequentially treated with a cocktail mixture of 95% TFA/H 2 O (1.5 ml). The mixture was vigorously agitated at room temperature. After being agitated for 3 h, the reaction mixture was filtered and dried in vacuo to provide crude Argadin (1) (24 mg, 84.5%). The use of HPLC purification (8% MeCN/H 2 O containing 0.05% TFA) furnished 1 (4.2 mg, 4.7%) as a colorless solid.
